Copyright
©The Author(s) 2017.
World J Hepatol. Feb 18, 2017; 9(5): 278-287
Published online Feb 18, 2017. doi: 10.4254/wjh.v9.i5.278
Published online Feb 18, 2017. doi: 10.4254/wjh.v9.i5.278
Figure 1 Vitamin D metabolism.
Vitamin D has diverse influences throughout the body as vitamin D receptors present on virtually every cell. The actions of vitamin D can be subdivided into two larger categories: Calcemic and non-calcemic actions. The non-calcemic actions of vitamin D are legion and have been reviewed elsewhere[6,54-58]. Reproduced with permission[6].
Figure 2 Flowchart of study selection process.
Eighteen hundred and twelve articles were identified using PubMed (n = 468)/EMBASE (n = 1269)/Cochrane (n = 23)/Scopus (n = 42)/LILACS (n = 10) search engines. Detailed evaluation of the articles by at least two independent reviewers (total of three) narrowed the studies to twelve (n = 2521) based upon inclusion and exclusion criteria as listed in Table 1.
Figure 3 Meta-analysis of the pooled data from the 12 included studies.
The odds ratio for severe fibrosis comparing low vitamin D levels was estimated by meta-analyzing studies including a total of 2521 patients. Details concerning the analytic strategy are provided in the Materials and Methods section.
- Citation: Dadabhai AS, Saberi B, Lobner K, Shinohara RT, Mullin GE. Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data. World J Hepatol 2017; 9(5): 278-287
- URL: https://www.wjgnet.com/1948-5182/full/v9/i5/278.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i5.278